© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
December 05, 2020
Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.
High levels of fetal hemoglobin have previously been linked to the mitigation of morbidity and mortality of sickle cell anemia.
Those without prior exposure to venetoclax experienced the most benefit.
December 04, 2020
This combination therapy may have a few advantages over standard corticosteroid regimens.